Microporous polysaccharide hemosphere absorbable hemostat (AristaAH®) use in re-operative cardiac surgical procedures

Brian A. Bruckner, Matthias Loebe

Research output: Contribution to journalArticle

Abstract

Patients undergoing re-operative cardiac surgical procedures present a great challenge with regard to obtaining hemostasis in the surgical field. Adhesions are ever-present and these patients are often on oral anti-coagulants and platelet inhibitors. As part of a well-planned surgical intervention, a systematic approach to hemostasis should be employed to decrease blood transfusion requirement and improve patient outcomes. Topical hemostatic agents can be a great help tothe surgeon in achieving surgical field hemostasis and are increasingly being employed. Our approach, to these difficultpatients, includes the systematic and planned use of AristaAH, which is a novel hemostatic agent whose use has proven safe and efficacious in our patient population.

Original languageEnglish (US)
Pages (from-to)96-98
Number of pages3
JournalUS Cardiology
Volume9
Issue number2
StatePublished - 2012
Externally publishedYes

Keywords

  • AristaAH
  • Cardiac
  • Hemostat
  • Re-do
  • Re-operative
  • Safe
  • Surgery
  • Transfusion

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Microporous polysaccharide hemosphere absorbable hemostat (AristaAH®) use in re-operative cardiac surgical procedures'. Together they form a unique fingerprint.

  • Cite this